First Look Analysts Research Calls for Thursday, March 23
This report was sent to Briefing.com subscribers earlier today. Upgrades: > Accolade (ACCD) upgraded to Buy from Neutral at Guggenheim; tgt $16 > Americold Realty Trust (COLD) upgraded to Equal Weight from Underweight at Barclays; tgt raised to $32 >…
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Accolade (ACCD) upgraded to Buy from Neutral at Guggenheim; tgt $16
> Americold Realty Trust (COLD) upgraded to Equal Weight from Underweight at Barclays; tgt raised to $32
> ArcelorMittal (MT) upgraded to Buy from Neutral at BofA Securities
> BellRing Brands (BRBR) upgraded to Buy from Hold at Truist; tgt raised to $40
> Inozyme Pharma (INZY) upgraded to Buy from Hold at Jefferies; tgt raised to $6
> Marathon Oil (MRO) upgraded to Buy from Neutral at Citigroup; tgt $27
> ORIC Pharmaceuticals (ORIC) upgraded to Buy from Neutral at H.C. Wainwright; tgt $16
> Pioneer Natural Resources (PXD) upgraded to Buy from Neutral at Citigroup; tgt raised to $210
> Regency Centers (REG) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $70
Downgrades:
> Amwell (AMWL) downgraded to Market Perform from Outperform at TD Cowen; tgt lowered to $2.50
> Boston Properties (BXP) downgraded to Equal Weight from Overweight at Barclays; tgt $57
> Chewy (CHWY) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $35
> Coinbase Global (COIN) downgraded to Perform from Outperform at Oppenheimer
> M&T Bank (MTB) downgraded to Peer Perform from Outperform at Wolfe Research
> nCino (NCNO) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
> Ovintiv (OVV) downgraded to Neutral from Buy at Citigroup; tgt lowered to $38
> Samsara (IOT) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt raised to $19
> SL Green Realty (SLG) downgraded to Underweight from Equal Weight at Barclays; tgt $22
Others:
> AMC Entertainment (AMC) resumed with a Sell at Citigroup; tgt $1.60
> Disc Medicine (IRON) initiated with an Outperform at BMO Capital Markets; tgt $40
> Dynatrace (DT) initiated with a Buy at Stifel; tgt $45
> HashiCorp (HCP) initiated with a Buy at BTIG Research; tgt $37
> IDEAYA Biosciences (IDYA) initiated with a Buy at Berenberg; tgt $26
> Intuitive Surgical (ISRG) initiated with an Outperform at William Blair
> Mobileye Global (MBLY) initiated with a Hold at WestPark Capital
> NVIDIA (NVDA) initiated with a Hold at WestPark Capital
> Qualcomm (QCOM) initiated with a Hold at WestPark Capital
> Roper (ROP) initiated with a Neutral at Mizuho; tgt $475
> Select Energy Services (WTTR) initiated with a Strong Buy at Raymond James; tgt $12
> Sociedad Quimica y Minera (SQM) initiated with an Outperform at Bradesco BBI
> Talos Energy (TALO) initiated with an Overweight at KeyBanc Capital Markets; tgt $18
> Western Alliance Bancorp (WAL) initiated with an Outperform at Hovde Group
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.